HIGHLIGHTS
- who: March and colleagues from the National Technical University of Athens, Greece have published the paper: Prevalence of COVID-19 outcomes in patients referred to opioid agonist treatment centers, in the Journal: (JOURNAL) of 20/03/2018
SUMMARY
Opioids are endogenous peptides (β-endorphin, encephalin, and met-encephalin) or exogenous substances (e_g, morphine, methadone, etc.) that act through activating opioid receptors known as µ, κ, and δ (Feng et_al, 2012). Opioid receptors are distributed in the immune cells such as lymphocytes, macrophages, neutrophils, Frontiers in Pharmacology frontiersin.org 10.3389/fphar.2023.1105176 helps the coronavirus to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.